Insulet Corp at Morgan Stanley Global Healthcare Conference Transcript
Great. Good afternoon, and thank you again for joining us. Welcome to the, again, second day of the Morgan Stanley Healthcare Conference. I'm Cecilia Furlong, a medical device analyst here at Morgan Stanley. It's my pleasure to have Insulet with us today, CEO, Jim Hollingshead; CFO, Wayde McMillan.
Really quickly, just disclosures, please see morganstanley.com/researchdisclosures. With that, again, thank you both for being here today.
It's a pleasure. Thanks, Cecilia.
Questions & Answers
And I guess to start, just kind of looking at how you're thinking about the business. You had an experience, I think, and would love to kind of hear your perspective, taking in what's traditionally viewed DME type of product and really layering in a lot more of technical component software, either
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
